Phase 3 Retinopathy of Prematurity Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
Retinopathy of PrematurityDexmedetomidine
Assaf-Harofeh Medical Center30 enrolled1 locationNCT06067958
Recruiting
Phase 2Phase 3
Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Retinopathy of Prematurity
Asociación para Evitar la Ceguera en México1 locationNCT00346814